These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6140097)

  • 21. Neuroleptic malignant syndrome.
    Weinberg S; Twersky RS
    Anesth Analg; 1983 Sep; 62(9):848-50. PubMed ID: 6136239
    [No Abstract]   [Full Text] [Related]  

  • 22. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD; Hake L; Benjamin AB; Adityanjee A
    J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
    [No Abstract]   [Full Text] [Related]  

  • 23. [Neuroleptic malignant syndrome and acute life-threatening catatonia--two contrasting disease entities?].
    Heils A; Lesch KP
    Fortschr Neurol Psychiatr; 1997 Jan; 65(1):8-15. PubMed ID: 9132369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticholinergic exacerbation of phenothiazine-induced extrapyramidal syndrome.
    Alpert M; Diamond F; Laski EM
    Am J Psychiatry; 1976 Sep; 133(9):1073-5. PubMed ID: 961932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Malignant neuroleptic syndrome].
    Courtine JC; Blot P
    Nouv Presse Med; 1981 May; 10(21):1749. PubMed ID: 6112732
    [No Abstract]   [Full Text] [Related]  

  • 26. [The malignant neuroleptic syndrome].
    Hilpert F; Cohen A; Auzépy P
    Rev Prat; 1984 Mar; 34(13):633-9. PubMed ID: 6143390
    [No Abstract]   [Full Text] [Related]  

  • 27. Catatonia-like events after valproic acid with risperidone and sertraline.
    Lauterbach EC
    Neuropsychiatry Neuropsychol Behav Neurol; 1998 Jul; 11(3):157-63. PubMed ID: 9742515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Malignant neuroleptic syndrome].
    Devos P; Destee A; Warot P
    LARC Med; 1984 May; 4(5):316-9. PubMed ID: 6147732
    [No Abstract]   [Full Text] [Related]  

  • 29. Suspected neuroleptic catatonia induced by clozapine.
    Biancosino B; Zanchi P; Agostini M; Grassi L
    Can J Psychiatry; 2001 Jun; 46(5):458. PubMed ID: 11441795
    [No Abstract]   [Full Text] [Related]  

  • 30. [Amantadine in malignant neuroleptic syndrome].
    Rojtman M; Apter E; Lahav S; Tiano S
    Harefuah; 1981 Apr; 100(7):333. PubMed ID: 6115795
    [No Abstract]   [Full Text] [Related]  

  • 31. Catatonia, neuroleptics and brain damage--a case report.
    Chandran M; El-Shazly M
    J Psychopharmacol; 2009 Mar; 23(2):223-6. PubMed ID: 18562406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and management of the neuroleptic malignant syndrome.
    Bond WS
    Clin Pharm; 1984; 3(3):302-7. PubMed ID: 6145537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Subjective side effects of neuroleptic agents].
    Noll RL; Hoencamp E; Nolen WA
    Ned Tijdschr Geneeskd; 1991 Nov; 135(45):2113-6. PubMed ID: 1682826
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuroleptic malignant syndrome.
    Br Med J (Clin Res Ed); 1983 Jul; 287(6385):128-9. PubMed ID: 6407706
    [No Abstract]   [Full Text] [Related]  

  • 35. Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment.
    Schwartz M; Weller B; Erdreich M; Sharf B
    J Clin Psychiatry; 1995 May; 56(5):212. PubMed ID: 7737962
    [No Abstract]   [Full Text] [Related]  

  • 36. Caution is still needed when prescribing atypical antipsychotics.
    Carey S
    Br J Hosp Med (Lond); 2008 May; 69(5):299. PubMed ID: 18557562
    [No Abstract]   [Full Text] [Related]  

  • 37. [A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine].
    Konishi K; Fujimoto K; Kubota M; Ogawa H
    Masui; 1997 Apr; 46(4):547-8. PubMed ID: 9128030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatments for neuroleptic malignant syndrome.
    West AP
    J Clin Psychiatry; 1984 Mar; 45(3):144. PubMed ID: 6142037
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
    Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P
    Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083
    [No Abstract]   [Full Text] [Related]  

  • 40. Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.
    Tsai JH; Yang P; Yen JY; Chen CC; Yang MJ
    Pharmacotherapy; 2005 Aug; 25(8):1156-9. PubMed ID: 16207109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.